The Sickle Cell Data Collection (SCDC) program collects health information about people with sickle cell disease (SCD) in an effort to study changes related to their health over time.
A new data brief, “Hydroxyurea Use Among Medicaid Beneficiaries with Sickle Cell Disease in California and Georgia, 2006–2016” shows that during an 11-year period, the use of hydroxyurea (HU) among Medicaid beneficiaries with SCD who lived in California or Georgia increased. However, many beneficiaries with severe complications of SCD do not use HU.
Share this resource with your family, friends, and colleagues!
Want to learn more about SCD? Visit our SCD website.
For the latest updates and resources, follow us on Twitter @CDC_NCBDDD.
.png)
No hay comentarios:
Publicar un comentario